{site_meta && site_meta.display_name} Logo

InvestorBrandNetwork (IBN)

The latest articles, editorials and news releases from InvestorBrandNetwork (IBN), a growing Investor Brand Platform.

RSS Feed for InvestorBrandNetwork (IBN)

AINewsBreaks – Wearable Devices Ltd. (NASDAQ: WLDS, WLDSW) Launches AI-Powered Touchless Neural Control Project for Military Use

August 6, 2025Wearable Devices (NASDAQ: WLDS, WLDSW), a developer of AI-powered touchless sensing wearables, announced the launch of a military-focused project to advance human-machine interface (HMI) technology. The initiative aims to deliver a neural control system enabling soldiers to operate tactical systems through intuitive gestures without physical contact.


Nutriband Inc. (NASDAQ: NTRB) Navigates Drug-Delivery Challenges with Innovation in Abuse-Deterrent Tech

August 6, 2025 Drug delivery plays a critical role in modern healthcare, but when it comes to potent opioids such as fentanyl, the stakes are particularly high Nutriband is developing Aversa(TM), a proprietary abuse-deterrent transdermal technology designed to prevent diversion, misuse, abuse and accidental exposure Nutriband’s Aversa(TM) fentanyl patch is estimated to have a market potential of $80 million to $200 million annually within five years of launch Developing safe, effective and abuse-deterrent delivery systems for controlled substances such as fentanyl is a formidable challenge, and Nutriband (NASDAQ: NTRB) is positioning itself at the forefront of that effort. The company is pioneering transdermal technologies to deliver medications that require careful balancing of patient access with strong mitigation against misuse.


BioMedNewsBreaks — Lantern Pharma (NASDAQ: LTRN) Subsidiary Starlight Therapeutics Cleared by FDA to Begin GBM Combination Trial

August 6, 2025Lantern Pharma (NASDAQ: LTRN) announced that its wholly owned subsidiary, Starlight Therapeutics, has received FDA clearance for an Investigational New Drug (“IND”) application to initiate a Phase Ib/2a clinical trial of STAR-001 (LP-184) in combination with spironolactone for patients with glioblastoma multiforme (“GBM”) at first progression. The study will evaluate safety, tolerability and preliminary efficacy in recurrent GBM, a highly aggressive brain cancer with limited treatment options.


AI, Robotics Are Reshaping the Future of Hospitality

August 6, 2025NetworkNewsWire Editorial Coverage: The hospitality industry is rapidly evolving as artificial intelligence (“AI”) and robotics bring sweeping change. Hotels that implement automation are seeing operational costs drop by 30%–40%, along with enhanced guest satisfaction and stronger revenue strategies.


Clinical Progress in Rare Disease Signals Long-Term Revenue Potential for Innovators

August 6, 2025NetworkNewsWire Editorial Coverage: As the American population gets older, chronic and rare diseases are becoming a significant healthcare issue, particularly for older adults. The aging population’s increasing life expectancy also leads to more complex healthcare needs, especially for conditions that are both chronic and difficult to diagnose.


TechMediaBreaks – Bollinger Innovations, Inc. (NASDAQ: BINI) Offers $7,500 Price Cut on Mullen ONE and THREE EVs Ahead of Incentive Deadline

August 6, 2025Bollinger Innovations (NASDAQ: BINI), an electric vehicle manufacturer, announced $7,500 in additional price adjustments for commercial customers purchasing existing inventory of its Mullen ONE and Mullen THREE EVs. With MSRPs now set at $27,000 and $61,000 respectively, the incentive—combined with a $7,500 Inflation Reduction Act credit for deliveries before September 30—positions both models as high-value options in the Class 1 and Class 3 commercial EV segments.


New Genetic Discovery Could Boost Cancer Immunotherapy

August 6, 2025A recent genetic discovery has the potential to boost the effectiveness of cancer immunotherapy treatments. According to a study published in the journal Nature, the genetic discovery may improve cancer treatment outcomes in certain patients.


Why Trump is Obsessed with Tariffs on Aluminum, Steel and Copper

August 6, 2025Many have been wondering why President Trump levied 50% tariffs on aluminum, steel and copper despite these three metals being critical to many manufacturing processes. Looking deeper, it emerges that there are deeper reasons than just economics.


Toyota Appears to Be Reembracing Electric Vehicles

August 6, 2025Toyota has long been known for its careful and slow approach when it comes to electric vehicles. For years, the company focused more on hybrid models rather than fully electric ones.


InvestorNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Portfolio Company CEO Honored at 2025 STIMULATE Conference

August 5, 2025Aditxt (NASDAQ: ADTX), announced that Saundra Pelletier, CEO of Evofem Biosciences—its pending acquisition target—has received the Trailblazing Female Founders Award at the 2025 STIMULATE Conference in Nashville. Recognized for advancing women’s sexual and reproductive health, Pelletier leads Evofem, the developer of hormone-free contraceptive PHEXXI(R) and SOLOSEC(R), an oral treatment for bacterial vaginosis and trichomoniasis.